Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 1
1987 1
1988 3
1989 1
1991 2
1992 2
1994 1
1997 2
1998 4
1999 3
2001 3
2002 1
2003 1
2004 1
2005 4
2006 1
2009 3
2010 1
2017 2
2018 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Malignant Extragonadal Germ Cell Tumor"
Page 1
Malignant recurrence after mature Sacrococcygeal teratoma: A meta-analysis and review of the literature.
Kops AL, Hulsker CC, Fiocco M, Zsiros J, Mavinkurve-Groothuis AMC, Looijenga LH, van der Steeg AF, Wijnen MH. Kops AL, et al. Crit Rev Oncol Hematol. 2020 Dec;156:103140. doi: 10.1016/j.critrevonc.2020.103140. Epub 2020 Oct 23. Crit Rev Oncol Hematol. 2020. PMID: 33142194 Review.
BACKGROUND AND AIMS: Sacrococcygeal teratoma (SCT) is a rare extragonadal germ cell tumour mostly diagnosed during infancy and early childhood. ...Random effect models for mature recurrence and malignant recurrence after an …
BACKGROUND AND AIMS: Sacrococcygeal teratoma (SCT) is a rare extragonadal germ cell tumour mostly diagnosed duri …
Adult primary extragonadal germ cell tumors: Treatment results and long-term follow-up.
Andac A, Mert B, Sevil B, Burak S, Haluk O. Andac A, et al. Med Pediatr Oncol. 2003 Jul;41(1):49-53. doi: 10.1002/mpo.10136. Med Pediatr Oncol. 2003. PMID: 12764743
BACKGROUND: Primary extragonadal germ cell tumors (PEGCT) are rare neoplasms. They have a poor prognosis, different behavior, and natural course compared to their gonadal counterparts. ...The 5-year actuarial event-free and overall survival were 63.4 a …
BACKGROUND: Primary extragonadal germ cell tumors (PEGCT) are rare neoplasms. They have a poor prognosis, differ …
Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Societe Francaise des Cancers de l'Enfant).
Sudour-Bonnange H, Faure-Conter C, Martelli H, Hameury F, Fresneau B, Orbach D, Vérité C. Sudour-Bonnange H, et al. Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26494. Epub 2017 Mar 17. Pediatr Blood Cancer. 2017. PMID: 28306215 Clinical Trial.
PURPOSE: To examine the clinical presentation, treatment and results in children and adolescents with primary mediastinal (PM) and retroperitoneal (RP) germ cell tumors (GCTs). METHODS: The TGM95 trial for malignant GCTs was conducted in France …
PURPOSE: To examine the clinical presentation, treatment and results in children and adolescents with primary mediastinal (PM) and re …
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Ramanathan S, Prasad M, Vora T, Badira CP, Kembhavi S, Ramadwar M, Khanna N, Laskar S, Muckaden MA, Qureshi S, Banavali S, Chinnaswamy G. Ramanathan S, et al. Pediatr Blood Cancer. 2023 Apr;70(4):e30179. doi: 10.1002/pbc.30179. Epub 2023 Jan 16. Pediatr Blood Cancer. 2023. PMID: 36645132
BACKGROUND AND AIMS: Data on the outcome and prognostic indicators in extracranial relapsed/refractory germ cell tumors (rel/ref-GCTs) in children are limited to a few studies. ...The rel/ref-testicular GCTs had the best chance of salvage despite a second recurre …
BACKGROUND AND AIMS: Data on the outcome and prognostic indicators in extracranial relapsed/refractory germ cell tumors (rel/r …
Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
Loehrer PJ Sr, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH. Loehrer PJ Sr, et al. Ann Intern Med. 1988 Oct 1;109(7):540-6. doi: 10.7326/0003-4819-109-7-540. Ann Intern Med. 1988. PMID: 2844110
STUDY OBJECTIVE: To determine the efficacy of the addition of ifosfamide to cisplatin plus etoposide (VIP), or vinblastine (VeIP), in patients with recurrent germ cell tumors. DESIGN: Nonrandomized, prospective phase II trial. ...PATIENTS: Fifty-six of …
STUDY OBJECTIVE: To determine the efficacy of the addition of ifosfamide to cisplatin plus etoposide (VIP), or vinblastine (VeIP), in patien …
Mixed extragonadal germ cell tumour of the prostate.
Antunes HP, Almeida R, Sousa V, Figueiredo A. Antunes HP, et al. BMJ Case Rep. 2018 Jul 10;2018:bcr2017223603. doi: 10.1136/bcr-2017-223603. BMJ Case Rep. 2018. PMID: 29991542 Free PMC article.
Extragonadal germ cell tumours (EGGCTs) originated in prostate are extremely rare, with <20 cases described in the literature. ...After 12 months of follow-up, the patient is alive and free of recurrence....
Extragonadal germ cell tumours (EGGCTs) originated in prostate are extremely rare, with <20 cases described in the l …
High-dose chemotherapy with autologous stem-cell support for germ cell tumors: a critical review.
Sobecks RM, Vogelzang NJ. Sobecks RM, et al. Semin Oncol. 1999 Feb;26(1):106-18. Semin Oncol. 1999. PMID: 10073567 Review.
High-dose chemotherapy (HDC) with autologous stem-cell support (ASCS) has been investigated in patients with cisplatin-resistant, relapsed, or poor-prognosis germ cell tumor (GCT). ...There has been only one phase III trial and it did not show a …
High-dose chemotherapy (HDC) with autologous stem-cell support (ASCS) has been investigated in patients with cisplatin-resistant, rel …
Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report.
Tobiume M, Aoki S, Nishikawa G, Muramatsu H, Ono K, Morinaga S, Hara K, Ando N, Ono K, Nishibata C, Hidano A, Nakagawa M, Takahashi I, Matsubara K, Yamada Y. Tobiume M, et al. J Med Case Rep. 2021 Feb 5;15(1):59. doi: 10.1186/s13256-021-02667-y. J Med Case Rep. 2021. PMID: 33541424 Free PMC article.
BACKGROUND: Extragonadal germ cell tumor (EGCT) is a relatively rare condition, reportedly representing 3-7% of all germ cell tumors. ...After EGCT treatment, such patients must be closely monitored for testicular recurrences and o …
BACKGROUND: Extragonadal germ cell tumor (EGCT) is a relatively rare condition, reportedly representing 3-7% of …
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.
Loehrer PJ Sr, Gonin R, Nichols CR, Weathers T, Einhorn LH. Loehrer PJ Sr, et al. J Clin Oncol. 1998 Jul;16(7):2500-4. doi: 10.1200/JCO.1998.16.7.2500. J Clin Oncol. 1998. PMID: 9667270 Clinical Trial.
PURPOSE: This study was designed to assess the effectiveness of vinblastine, ifosfamide, and cisplatin (VeIP) as second-line therapy in patients with recurrent germ cell tumors with previous treatment with cisplatin plus etoposide, usually in combination with …
PURPOSE: This study was designed to assess the effectiveness of vinblastine, ifosfamide, and cisplatin (VeIP) as second-line therapy in pati …
The treatment of extragonadal seminoma.
Jain KK, Bosl GJ, Bains MS, Whitmore WF, Golbey RB. Jain KK, et al. J Clin Oncol. 1984 Jul;2(7):820-7. doi: 10.1200/JCO.1984.2.7.820. J Clin Oncol. 1984. PMID: 6204019
Primary extragonadal seminoma (EGS) is a rare tumor of young adults that often presents with bulky primary tumors and metastatic disease. ...Combined modality therapy including initial chemotherapy containing high doses of cisplatin provided rapid reduction in tu …
Primary extragonadal seminoma (EGS) is a rare tumor of young adults that often presents with bulky primary tumors and metastat …
43 results